Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$231K Buy
2,625
+26
+1% +$2.14K 0.08% 195
2025
Q2
$206K Sell
2,599
-870
-25% -$69.2K 0.06% 262
2025
Q1
$311K Buy
3,469
+3
+0.1% +$280 0.1% 201
2024
Q4
$345K Buy
3,466
+13
+0.4% +$1.34K 0.11% 184
2024
Q3
$392K Buy
3,453
+587
+20% +$69.7K 0.14% 166
2024
Q2
$355K Sell
2,866
-130
-4% -$16.7K 0.13% 171
2024
Q1
$327K Hold
2,996
0.13% 167
2023
Q4
$327K Sell
2,996
-70
-2% -$7.27K 0.13% 167
2023
Q3
$316K Buy
3,066
+441
+17% +$47.5K 0.1% 170
2023
Q2
$231K Buy
2,625
+98
+4% +$11.1K 0.08% 213
2023
Q1
$269K Buy
+2,527
New +$273K 0.08% 194
2020
Q2
Sell
-475
Closed -$35K 259
2020
Q1
$35K Buy
+475
New +$37.3K 0.19% 66

Other funds holding MRK

Lion Street Advisors's MRK Position: Q3 2025 in Review

Lion Street Advisors increased its Merck (MRK) stake by 1% in Q3 2025, buying an estimated $2.14K and bringing the position to 2,625 shares worth $231K. The position accounts for 0.08% of the portfolio, ranked #195.

Lion Street Advisors first reported a position in MRK in Q1 2020 and has held it in 12 quarters since. The position peaked at $392K in Q3 2024. 3,316 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • Lion Street Advisors held 2,625 shares of Merck worth $231K as of Q3 2025.
  • Lion Street Advisors bought 26 Merck shares in Q3 2025, an estimated $2.14K.
  • Merck made up 0.08% of Lion Street Advisors's portfolio in Q3 2025, its #195 holding.
  • Lion Street Advisors first reported a position in Merck in Q1 2020 and has held it in 12 quarters since.
  • Lion Street Advisors's Merck position peaked at $392K in Q3 2024.
  • 3,316 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Lion Street Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.